Practice Guidelines

Preventive and clinical practice guidelines are based on the health needs and opportunities for improvement identified as part of the Quality Assurance Program Improvement (QAPI) program. Whenever possible, Sunflower Health Plan adopts preventive and clinical practice guidelines that are published by nationally recognized organizations or government institutions as well as state-wide collaborative and/or a consensus of healthcare professionals in the applicable field.

Preventative Care

Final Recommendation Statement Gonorrhea and Chlamydia: Screening, September 2014 - U.S. Preventive Services Task Force (USPSTF)

Disease Management

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2017 Report) - The Global Initiative for Chronic Obstructive Lung Disease (GOLD)

 

  • Evidence-Based Management of Sickle Cell Disease. Expert Panel Report, 2014 - U.S. Department of Health and Human Services; National Institutes of Health; National Heart, Lung, and Blood Institute
  • Sickle Cell Disease, Recommendations (Last updated September 14, 2015) - Centers for Disease Control and Prevention (CDC)
  • The Management of Sickle Cell Disease, Fourth Edition (2004) National Institutes of Health; National Heart, Lung, and Blood Institute

Behavioral Health

Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders (Revised: 2/2007) - American Academy of Child and Adolescent Psychiatry (AACAP)

Practice Guideline for the Treatment of Patients with Panic Disorder. Second Edition. (January 2009) - American Psychiatric Association (APA)

Practice parameter for the psychiatric assessment and management of physically ill children and adolescents (February 2009) - American Academy of Child and Adolescent Psychiatry (AACAP)

Practice parameter for the use of psychotropic medication in children and adolescents (9/2009) - American Academy of Child and Adolescent Psychiatry (AACAP)